USD
$0.00
(0.00%
)At Close (As of Sep 8, 2025)
$2.06B
Market Cap
-
P/E Ratio
-0.69
EPS
$96.56
52 Week High
$52.50
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $364M |
Total Revenue | $614M |
Cost Of Revenue | $250M |
Costof Goods And Services Sold | $250M |
Operating Income | $584K |
Selling General And Administrative | $250M |
Research And Development | $45M |
Operating Expenses | $364M |
Investment Income Net | - |
Net Interest Income | -$18M |
Interest Income | - |
Interest Expense | $18M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $68M |
Income Before Tax | -$22M |
Income Tax Expense | -$3.7M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$19M |
Comprehensive Income Net Of Tax | - |
Ebit | $11M |
Ebitda | $79M |
Net Income | -$19M |
Field | Value (USD) |
---|---|
Total Assets | $1.3B |
Total Current Assets | $528M |
Cash And Cash Equivalents At Carrying Value | $145M |
Cash And Short Term Investments | $145M |
Inventory | $137M |
Current Net Receivables | $222M |
Total Non Current Assets | $756M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $542M |
Intangible Assets Excluding Goodwill | $542M |
Goodwill | $60M |
Investments | - |
Long Term Investments | - |
Short Term Investments | $6.3M |
Other Current Assets | $18M |
Other Non Current Assets | - |
Total Liabilities | $855M |
Total Current Liabilities | $194M |
Current Accounts Payable | $46M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $9.2M |
Total Non Current Liabilities | $661M |
Capital Lease Obligations | - |
Long Term Debt | $615M |
Current Long Term Debt | $9.2M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $624M |
Other Current Liabilities | $132M |
Other Non Current Liabilities | $26M |
Total Shareholder Equity | $429M |
Treasury Stock | - |
Retained Earnings | -$100M |
Common Stock | $2K |
Common Stock Shares Outstanding | $19M |
Field | Value (USD) |
---|---|
Operating Cashflow | $64M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $68M |
Capital Expenditures | $17M |
Change In Receivables | - |
Change In Inventory | -$21M |
Profit Loss | - |
Cashflow From Investment | -$405M |
Cashflow From Financing | $265M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | $1.6M |
Dividend Payout Common Stock | $1.6M |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | -$11M |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$19M |
Field | Value (USD) |
---|---|
Gross Profit | $364M |
Total Revenue | $614M |
Cost Of Revenue | $250M |
Costof Goods And Services Sold | $250M |
Operating Income | $584K |
Selling General And Administrative | $250M |
Research And Development | $45M |
Operating Expenses | $364M |
Investment Income Net | - |
Net Interest Income | -$18M |
Interest Income | - |
Interest Expense | $18M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $68M |
Income Before Tax | -$22M |
Income Tax Expense | -$3.7M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$19M |
Comprehensive Income Net Of Tax | - |
Ebit | $11M |
Ebitda | $79M |
Net Income | -$19M |
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets brand-name and generic prescription pharmaceuticals in the United States and Canada. The company is headquartered in Baudette, Minnesota.